Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kennedy Associates Real Estate Counsel was a prominent Seattle-based real estate investment advisory firm that specialized in managing institutional capital. In 2010, the company merged with Bentall to form Bentall Kennedy, which subsequently merged with GreenOak Real Estate in 2019 to become BentallGreenOak (BGO). The firm is highly relevant to the life sciences and healthcare sectors through its extensive portfolio of specialized laboratory spaces, research and development facilities, and medical office buildings. It provides the critical physical infrastructure required by biotech and pharmaceutical companies to conduct clinical research and manufacturing. Today, as part of BGO, the entity remains one of the largest global dedicated investors in life science real estate.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kennedy Associates Real Estate Counsel.